Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

RedHill Biopharma (RDHL) Times Interest Earned (2016 - 2023)

RedHill Biopharma has reported Times Interest Earned over the past 12 years, most recently at $27.91 for Q2 2023.

  • Quarterly Times Interest Earned rose 1184.06% to $27.91 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was -$1.2 through Jun 2023, up 80.7% year-over-year, with the annual reading at -$5.45 for FY2025, 27.37% down from the prior year.
  • Times Interest Earned was $27.91 for Q2 2023 at RedHill Biopharma, up from -$69.07 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $167.3 in Q2 2019 and troughed at -$69.07 in Q1 2023.
  • The 5-year median for Times Interest Earned is $4.29 (2020), against an average of $15.0.
  • Year-over-year, Times Interest Earned surged 2905.64% in 2019 and then plummeted 1723.72% in 2023.
  • A 5-year view of Times Interest Earned shows it stood at $62.91 in 2019, then crashed by 93.12% to $4.33 in 2020, then plummeted by 987.5% to -$38.41 in 2021, then rose by 20.52% to -$30.53 in 2022, then soared by 191.42% to $27.91 in 2023.
  • Per Business Quant, the three most recent readings for RDHL's Times Interest Earned are $27.91 (Q2 2023), -$69.07 (Q1 2023), and -$30.53 (Q4 2022).